Grace Therapeutics Inc. logo

Grace Therapeutics Inc. (GRCE)

Market Open
12 Jun, 14:01
NASDAQ (CM) NASDAQ (CM)
$
2. 29
-0.01
-0.4348%
$
36.98M Market Cap
- P/E Ratio
- Div Yield
43,596 Volume
0 Eps
$ 2.3
Previous Close
Investors:
Add Transaction
Day Range
2.27 2.33
Year Range
1.79 5.18
Want to track GRCE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Grace Therapeutics Inc. logo
GRCE Grace Therapeutics Inc.
12 Feb 2026
-
-
Grace Therapeutics Inc. logo
GRCE Grace Therapeutics Inc.
12 Nov 2025
-
-
Grace Therapeutics Inc. logo
GRCE Grace Therapeutics Inc.
8 Aug 2025
-
-
Grace Therapeutics Inc. logo
GRCE Grace Therapeutics Inc.
23 Jun 2025
-
0.05
Grace Therapeutics Inc. logo
GRCE Grace Therapeutics Inc.
17 Feb 2025
-
-
Grace Therapeutics Inc. logo
GRCE Grace Therapeutics Inc.
13 Nov 2024
-
-

GRCE Earnings Reports FAQ

What is the earnings per share (EPS) for GRCE?

The current EPS is 0.

What is the company's earnings growth rate?

Grace Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Grace Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Grace Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for GRCE at this time, as Grace Therapeutics Inc has no recent EPS data to calculate it.